Role of Tc-99m pertechnetate for remnant scintigraphy, post-thyroidectomy, and serum thyroglobulin and antithyroglobulin antibody levels in the patients with differentiated thyroid cancer.

Aydin F., Sipahi M., Budak E., Oner A. O., Demirelli S., Erkilic M., ...Daha Fazla

Annals of nuclear medicine, cilt.30, sa.1, ss.60-7, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Sayı: 1
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1007/s12149-015-1031-1
  • Dergi Adı: Annals of nuclear medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.60-7
  • Anahtar Kelimeler: Thyroid carcinoma, Technetium-99m pertechnetate, Iodine-131, Remnant ablation, FOLLOW-UP, I-131 SCANS, MBQ I-131, CARCINOMA, PAPILLARY, MANAGEMENT, ABLATION, THERAPY, DISEASE, TC-99M-PERTECHNETATE
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Aim Postoperative scanning may help to identify patients with differentiated thyroid cancer (DTC); however, low dose I-131 can lead to stunning and suboptimal response to ablative therapy. The aim of this retrospective study is to compare postablative I-131 scintigraphy with post-thyroidectomy Tc-99m pertechnetate scintigraphy, serum thyroglobulin (Tg) and antithyroglobulin antibody (TgAb) levels in patients with DTC.